- Home
- CDNA vs GPRE Comparison
CDNA vs GPRE Comparison
Compare CDNA & GPRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- GPRE
- Stock Information
- Founded
- CDNA 1998
- GPRE 2004
- Country
- CDNA United States
- GPRE United States
- Employees
- CDNA N/A
- GPRE N/A
- Industry
- CDNA Medical Specialities
- GPRE Major Chemicals
- Sector
- CDNA Health Care
- GPRE Industrials
- Exchange
- CDNA Nasdaq
- GPRE Nasdaq
- Market Cap
- CDNA 712.2M
- GPRE 631.4M
- IPO Year
- CDNA 2014
- GPRE N/A
- Fundamental
- Price
- CDNA $18.03
- GPRE $9.66
- Analyst Decision
- CDNA Buy
- GPRE Hold
- Analyst Count
- CDNA 7
- GPRE 8
- Target Price
- CDNA $26.00
- GPRE $8.69
- AVG Volume (30 Days)
- CDNA 1.2M
- GPRE 2.0M
- Earning Date
- CDNA 11-04-2025
- GPRE 11-05-2025
- Dividend Yield
- CDNA N/A
- GPRE N/A
- EPS Growth
- CDNA N/A
- GPRE N/A
- EPS
- CDNA 1.22
- GPRE N/A
- Revenue
- CDNA $357,998,000.00
- GPRE $2,246,853,000.00
- Revenue This Year
- CDNA $12.73
- GPRE N/A
- Revenue Next Year
- CDNA $11.90
- GPRE N/A
- P/E Ratio
- CDNA $14.75
- GPRE N/A
- Revenue Growth
- CDNA 14.46
- GPRE N/A
- 52 Week Low
- CDNA $10.96
- GPRE $3.14
- 52 Week High
- CDNA $26.37
- GPRE $12.31
- Technical
- Relative Strength Index (RSI)
- CDNA 67.03
- GPRE 46.51
- Support Level
- CDNA $15.60
- GPRE $9.61
- Resistance Level
- CDNA $17.09
- GPRE $10.62
- Average True Range (ATR)
- CDNA 1.02
- GPRE 0.75
- MACD
- CDNA 0.15
- GPRE -0.05
- Stochastic Oscillator
- CDNA 95.64
- GPRE 14.95
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.